Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020
GHDx Entry last modified on: Mar 14, 2022
Disease outbreaks
Dataset Records for Disease outbreaks
Displaying 551 - 600 of 819
The seroprevalence and trends of SARS-CoV-2 in Delhi, India: A repeated population-based seroepidemiological study. Preprint
GHDx Entry last modified on: May 12, 2022
Seroprevalence of SARS-CoV-2 infection in the craft and manual worker population of Qatar
GHDx Entry last modified on: Jun 17, 2021
Performance of rapid IgM-IgG combined antibody tests in the occupational surveillance of COVID-19 in Colombian enterprises
GHDx Entry last modified on: Mar 14, 2022
Surveillance and Seroprevalence: Evaluation of IgG antibodies for SARS-Cov2 by ELISA in the popular neighborhood Villa Azul, Quilmes, province of Buenos Aires, Argentina. Preprint
GHDx Entry last modified on: Mar 14, 2022
COVID-19 pandemic in Saint Petersburg, Russia: combining surveillance and population-based serological study data in May, 2020-April, 2021. Preprint
GHDx Entry last modified on: Mar 14, 2022
Finland COVID-19 Cases in the Infectious Disease Registry
COVID-19 Cases in the Infectious Disease Registry
Disease registry:
Epi surveillance
Mexico Health Secretary COVID-19 Daily Technical Release
Comunicado Técnico Diario COVID-19 MÉXICO
Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2: seroepidemiological pattern in northeastern Bulgaria
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands
GHDx Entry last modified on: Mar 14, 2022
Characteristics, comorbidities, 30-day outcome and in-hospital mortality of patients hospitalised with COVID-19 in a Swiss area - a retrospective cohort study
GHDx Entry last modified on: Mar 14, 2022
Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital
GHDx Entry last modified on: Mar 14, 2022
Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain
GHDx Entry last modified on: Mar 14, 2022
Characteristics and Outcomes of 241 Births to Women With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection at Five New York City Medical Centers
GHDx Entry last modified on: Mar 14, 2022
Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study
GHDx Entry last modified on: Mar 14, 2022
United States Provisional COVID-19 Death Counts by Sex, Age, and State
Vital registration:
Epi surveillance - Subnationally representative
Risk factors for severe acute respiratory syndrome coronavirus 2 infection in pregnant women
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence survey among 18,000 healthcare and administrative personnel at hospitals, pre-hospital services, and specialist practitioners in the Central Denmark Region. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Evidence for and level of herd immunity against SARS-CoV-2 infection: the ten-community study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Temporal trends of SARS-CoV-2 seroprevalence in transfusion blood donors during the first wave of the COVID-19 epidemic in Kenya
GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany
GHDx Entry last modified on: Jun 17, 2021
The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide survey in Karnataka, India
GHDx Entry last modified on: Feb 10, 2022
SARS-CoV-2 Seroprevalence in Lithuania: Results of National Population Survey. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich. Preprint
GHDx Entry last modified on: Mar 14, 2022
Sero-prevalence Findings from Metropoles in Pakistan: Implications for Assessing COVID-19 Prevalence and Case-fatality within a Dense, Urban Working Population. Preprint
GHDx Entry last modified on: Mar 14, 2022
Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults. Preprint
GHDx Entry last modified on: Mar 14, 2022
Population-based seroprevalence of SARS-CoV-2 is more than halfway through the herd immunity threshold in the State of Maranhao, Brazil. Preprint
GHDx Entry last modified on: May 12, 2022
Olfactory and Gustatory Outcomes in COVID-19: A Prospective Evaluation in Nonhospitalized Subjects
GHDx Entry last modified on: Mar 14, 2022
Neurological Manifestations in Critically Ill Patients With COVID-19: A Retrospective Study
GHDx Entry last modified on: Mar 14, 2022
Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 - COVID-NET, 13 States, March 1-August 22, 2020
GHDx Entry last modified on: Mar 14, 2022
Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study
GHDx Entry last modified on: Mar 14, 2022
A pandemic center's experience of managing pregnant women with COVID-19 infection in Turkey: A prospective cohort study
GHDx Entry last modified on: Mar 14, 2022
Influence of Race and Ethnicity on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Rates and Clinical Outcomes in Pregnancy
GHDx Entry last modified on: Mar 14, 2022
Low prevalence of antibodies against SARS-CoV-2 among voluntary blood donors in Guangzhou, China
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 in slums and non-slums of Mumbai, India, during June 29-July 19, 2020. Preprint.
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in Wuhan City and other places of China
GHDx Entry last modified on: Jun 17, 2021
Increased Mask Use and Fewer Gatherings Associated with Lower SARS-CoV-2 Seropositivity Among Young School-Age Children. Preprint
GHDx Entry last modified on: Mar 14, 2022
2019 Novel Coronavirus COVID-19 (2019-nCoV) Data Repository by Johns Hopkins CSSE
GHDx Entry last modified on: May 12, 2022
United States SafeGraph Social Distancing Metrics 2020
GHDx Entry last modified on: Apr 6, 2022
United Kingdom - England and Wales Deaths Registered Weekly, Provisional
GHDx Entry last modified on: May 12, 2022
A population-based study of the prevalence of COVID-19 infection in Espírito Santo, Brazil: methodology and results of the first stage. Preprint
GHDx Entry last modified on: May 12, 2022
Sero-surveillance (IgG) of SARS-CoV-2 among Asymptomatic General population of Paschim Medinipur District, West Bengal, India. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Recovery rate and factors associated with smell and taste disruption in patients with coronavirus disease 2019 [Pre-proof]
GHDx Entry last modified on: Mar 14, 2022
Olfactory and taste disorders in healthcare workers with COVID-19 infection
GHDx Entry last modified on: Mar 14, 2022
Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth
GHDx Entry last modified on: Mar 14, 2022
Analysis of vaginal delivery outcomes among pregnant women in Wuhan, China during the COVID-19 pandemic
GHDx Entry last modified on: Mar 14, 2022
Clinical Findings and Disease Severity in Hospitalized Pregnant Women With Coronavirus Disease 2019 (COVID-19)
GHDx Entry last modified on: Mar 14, 2022
Subscribe